Cargando…

Construction of the novel immune risk scoring system related to CD8(+) T cells in uterine corpus endometrial carcinoma

BACKGROUND: Uterine corpus endometrial carcinoma (UCEC) is a gynecological malignant tumor with high incidence and poor prognosis. Although immunotherapy has brought significant survival benefits to advanced UCEC patients, traditional evaluation indicators cannot accurately identify all potential be...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Ganghua, Yin, Zhijing, Fang, Jianing, Wu, Anshan, Chen, Guanjun, Cao, Ke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10286354/ https://www.ncbi.nlm.nih.gov/pubmed/37349706 http://dx.doi.org/10.1186/s12935-023-02966-y

Ejemplares similares

Construction of a novel molecular typing and scoring system for anoikis distinguishes between different prognostic risks and treatment responsiveness in low-grade glioma
por: Zhang, Ganghua, et al.
Publicado: (2023)

Construction of a Competitive Endogenous RNA Network in Uterine Corpus Endometrial Carcinoma
por: Ouyang, Dong, et al.
Publicado: (2019)

Erratum: Construction of a Competitive Endogenous RNA Network in Uterine Corpus Endometrial Carcinoma
por: Ouyang, Dong, et al.
Publicado: (2021)

The landscape and prognostic value of immune characteristics in uterine corpus endometrial cancer
por: Liu, Wenli, et al.
Publicado: (2021)

High expression of the ferroptosis‐associated MGST1 gene in relation to poor outcome and maladjusted immune cell infiltration in uterine corpus endometrial carcinoma
por: Yan, Jianing, et al.
Publicado: (2022)

CXCL9 correlates with antitumor immunity and is predictive of a favorable prognosis in uterine corpus endometrial carcinoma
por: Xue, Shen, et al.
Publicado: (2023)

Development of an Oxidative Phosphorylation-Related and Immune Microenvironment Prognostic Signature in Uterine Corpus Endometrial Carcinoma
por: Liu, Jinhui, et al.
Publicado: (2021)

ALDH2 promotes uterine corpus endometrial carcinoma proliferation and construction of clinical survival prognostic model
por: Cui, Yun-Qian, et al.
Publicado: (2021)

Identification of an immune gene signature for predicting the prognosis of patients with uterine corpus endometrial carcinoma
por: Zhou, Cankun, et al.
Publicado: (2020)

Tumor mutation burden in connection with immune-related survival in uterine corpus endometrial carcinoma
por: Zhao, Ling, et al.
Publicado: (2021)

Identification of immune-related gene signature for predicting prognosis in uterine corpus endometrial carcinoma
por: Song, Siyuan, et al.
Publicado: (2023)

Metabolism-associated molecular classification of uterine corpus endometrial carcinoma
por: Zhao, Munan, et al.
Publicado: (2023)

Construction of Oxidative Stress-Related Genes Risk Model Predicts the Prognosis of Uterine Corpus Endometrial Cancer Patients
por: Liu, Qin, et al.
Publicado: (2022)

Identification of the Prognostic Signature Associated With Tumor Immune Microenvironment of Uterine Corpus Endometrial Carcinoma Based on Ferroptosis-Related Genes
por: Liu, Jinhui, et al.
Publicado: (2021)

Mechanism investigation and experiment validation of capsaicin on uterine corpus endometrial carcinoma
por: Lin, Zhiheng, et al.
Publicado: (2022)

Construction of dysregulated long non-coding RNA-associated competing endogenous RNA network in uterine corpus endometrial carcinoma
por: Li, Na, et al.
Publicado: (2020)

Inflammation-Related LncRNAs Signature for Prognosis and Immune Response Evaluation in Uterine Corpus Endometrial Carcinoma
por: Gu, Hongmei, et al.
Publicado: (2022)

A prognostic model and immune regulation analysis of uterine corpus endometrial carcinoma based on cellular senescence
por: Gao, Lulu, et al.
Publicado: (2022)

Mammaglobin B may be a prognostic biomarker of uterine corpus endometrial cancer
por: Li, Jie, et al.
Publicado: (2020)

Prognostic significance of mutant-allele tumor heterogeneity in uterine corpus endometrial carcinoma
por: Hou, Yufang, et al.
Publicado: (2020)

Comprehensive Analysis of the Expression and Prognosis for MCM4 in Uterine Corpus Endometrial Carcinoma
por: Pei, Li-Peng, et al.
Publicado: (2022)

The Diagnostic Role of FGF 21 in Endometrial Cancer and Other Pathologies of the Uterine Corpus
por: Jagodzińska, Anna, et al.
Publicado: (2023)

Construction of N-7 methylguanine-related mRNA prognostic model in uterine corpus endometrial carcinoma based on multi-omics data and immune-related analysis
por: Zhao, Junde, et al.
Publicado: (2022)

RNF183 Is a Prognostic Biomarker and Correlates With Tumor Purity, Immune Infiltrates in Uterine Corpus Endometrial Carcinoma
por: Geng, Rong, et al.
Publicado: (2020)

Immune Infiltrates of m5C RNA Methylation-Related LncRNAs in Uterine Corpus Endometrial Carcinoma
por: Gu, Wen-Xiu, et al.
Publicado: (2022)

Immune and Metabolic Dysregulated Coding and Non-coding RNAs Reveal Survival Association in Uterine Corpus Endometrial Carcinoma
por: Liu, Da, et al.
Publicado: (2021)

Relationship between Prognosis, Immune Infiltration Level, and Differential Expression of PARVG Gene in Uterine Corpus Endometrial Carcinoma
por: Wang, Fei, et al.
Publicado: (2022)

Pan-Cancer Gene Analysis of m6A Modification and Immune Infiltration in Uterine Corpus Endometrial Carcinoma
por: Xie, Bing-fan, et al.
Publicado: (2022)

KNL1 is a prognostic and diagnostic biomarker related to immune infiltration in patients with uterine corpus endometrial carcinoma
por: He, Kang, et al.
Publicado: (2023)

Multiomics profile and prognostic gene signature of m6A regulators in uterine corpus endometrial carcinoma
por: Wang, Yizi, et al.
Publicado: (2020)

Myelin and Lymphocyte Protein (MAL): A Novel Biomarker for Uterine Corpus Endometrial Carcinoma
por: Li, Dong, et al.
Publicado: (2021)

Downregulation of PSAT1 inhibits cell proliferation and migration in uterine corpus endometrial carcinoma
por: Wang, Min, et al.
Publicado: (2023)

Identification of novel key genes associated with uterine corpus endometrial carcinoma progression and prognosis
por: Li, Haixia, et al.
Publicado: (2023)

Pan-cancer analysis identifies LIFR as a prognostic and immunological biomarker for uterine corpus endometrial carcinoma
por: Zhang, Fang, et al.
Publicado: (2023)

Elevated Expression of Gamma-Glutamyl Hydrolase Is Associated With Poor Prognosis and Altered Immune Signature in Uterine Corpus Endometrial Carcinoma
por: Yu, Cong, et al.
Publicado: (2022)

Comprehensive Analysis of Prognosis and Immune Landscapes Based on Lipid-Metabolism- and Ferroptosis-Associated Signature in Uterine Corpus Endometrial Carcinoma
por: Yang, Pusheng, et al.
Publicado: (2023)

Retracted: Relationship between Prognosis, Immune Infiltration Level, and Differential Expression of PARVG Gene in Uterine Corpus Endometrial Carcinoma
por: Imaging, Contrast Media & Molecular
Publicado: (2023)

Identification of m7G Methylation-Related miRNA Signature Associated with Survival and Immune Microenvironment Regulation in Uterine Corpus Endometrial Carcinoma
por: Chen, Rujun, et al.
Publicado: (2022)

LHX1 as a potential biomarker regulates EMT induction and cellular behaviors in uterine corpus endometrial carcinoma
por: Tian, Ye, et al.
Publicado: (2022)

Mesothelial cyst of uterine corpus misdiagnosed as leiomyoma
por: Mo, Shi-Ping, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ge5cfm6uo2emk2cvjbohhes9nu